Introduction and Aim: This study is to evaluate the levels of paraoxonase-1 and visfatin in diabetic and diabetic with hypothyroidism patients and to discover the relationship of paraoxonase-1 and visfatin levels in these patients. Materials and Methods: The study included 35 subjects in control group (G1), 35 with diabetes (G2), and 35 diabetes with hypothyroidism (G3), aged ranging 25-50 years for all the study groups and BMI with (20.5-25.4) Kg/m2. Serum and whole blood were used for estimating F.B.S., HbA1c%, lipid profile, T4, TSH, paraoxonase-1 and visfatin. Results: The results revealed a significant elevation in F.B.S., HbA1c%, TC, TG, VLDL and LDL in G2 and G3 compared to G1. The HDL levels showed a significant decrease in G2, G3 compared to G1. Also, showed significant reduction in T4 in G3 compared to G2 and G1. A significant elevation in TSH in G3 compared to G2 and G1 and a significant decrease in paraoxonase-1 but increase in visfatin for G3 more than G2 when compared to G1 were observed. Conclusion: The study concluded that paraoxonase -1 and visfatin are suggestive reliable markers for the diagnosis of thyroid disorder in diabetics with hypothyroidism depending on their relation with T4 and TSH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.